![divislab glp-1 novo nordisk relation inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs OC] Breaking down Novo Nordisk's](https://imgproxy.divecdn.com/tYkhDSglQdiY5REe0SoTuezSe4ztudxz0wb67KtoSak/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUzOTI3ODE1LmpwZw==.webp)
Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In Study 1 (participants not using positive airway pressure therapy), tirzepatide reduced the apnea-hypopnea index by an average of 25.3 events per hour compared to 5.3 events per hour with placebo
![divislab glp-1 novo nordisk relation inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs OC] Breaking down Novo Nordisk's](https://i.redd.it/tpu6ps7snghd1.png)
[7] Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H
![divislab glp-1 novo nordisk relation inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs OC] Breaking down Novo Nordisk's](https://substackcdn.com/image/fetch/$s_!nbi_!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F98631fbd-cf27-4433-ac0b-75368983b4d6_2250x1248.png)
However, the sharp demand for these products and the lack of FDA approval of compounded GLP-1 is raising concerns about the safety, effectiveness, and consistency of these medications, which have grown popular for weight loss
![divislab glp-1 novo nordisk relation inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs OC] Breaking down Novo Nordisk's](https://i.ytimg.com/vi/7Oi-udft-88/maxresdefault.jpg)
The federal judge then coordinates pretrial proceedings and discovery among all plaintiffs
![divislab glp-1 novo nordisk relation inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs OC] Breaking down Novo Nordisk's](https://assets.bwbx.io/images/users/iqjWHBFdfxIU/itdusyvQqP0c/v1/1200x800.jpg)
US$ 24.13
,aspect=ignore)
US$ 23.84
US$ 25.78
US$ 24.36
